These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12052148)

  • 41. Where are we today with personalized medicine?
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2012 Nov; 50(11):11-3. PubMed ID: 23066831
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The impact of molecular biology on psychiatric diseases].
    Salín-Pascual RJ; Alcocer Castillejos N
    Rev Invest Clin; 2003; 55(2):216-9. PubMed ID: 12827930
    [No Abstract]   [Full Text] [Related]  

  • 43. Personalized medicine: boon or budget-buster?
    Dean CE
    Ann Pharmacother; 2009 May; 43(5):958-62. PubMed ID: 19417115
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High-throughput screening: update on practices and success.
    Fox S; Farr-Jones S; Sopchak L; Boggs A; Nicely HW; Khoury R; Biros M
    J Biomol Screen; 2006 Oct; 11(7):864-9. PubMed ID: 16973922
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rubicon Genomics, Inc.
    Langmore JP
    Pharmacogenomics; 2002 Jul; 3(4):557-60. PubMed ID: 12164778
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease).
    Roses AD; Saunders AM; Huang Y; Strum J; Weisgraber KH; Mahley RW
    Pharmacogenomics J; 2007 Feb; 7(1):10-28. PubMed ID: 16770341
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetics and genomics in neuropsychopharmacology: the impact on drug discovery and development.
    Hurko O
    Eur Neuropsychopharmacol; 2001 Dec; 11(6):491-9. PubMed ID: 11704426
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The ATCG of drug discovery.
    Fernandes PB
    Curr Opin Mol Ther; 2000 Dec; 2(6):624-32. PubMed ID: 11249739
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic analysis of psychiatric disorders in humans.
    van Belzen MJ; Heutink P
    Genes Brain Behav; 2006; 5 Suppl 2():25-33. PubMed ID: 16681798
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Economic advantage of pharmacogenomics - clinical trials with genetic information.
    Ohashi W; Mizushima H; Tanaka H
    Stud Health Technol Inform; 2008; 136():585-90. PubMed ID: 18487794
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Critical appraisal of DNA microarrays in psychiatric genomics.
    Mirnics K; Levitt P; Lewis DA
    Biol Psychiatry; 2006 Jul; 60(2):163-76. PubMed ID: 16616896
    [TBL] [Abstract][Full Text] [Related]  

  • 52. How many genomics targets can a portfolio afford?
    Betz UA
    Drug Discov Today; 2005 Aug; 10(15):1057-63. PubMed ID: 16055022
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Something's got to give: psychiatric disease on the rise and novel drug development on the decline.
    Chandler DJ
    Drug Discov Today; 2013 Feb; 18(3-4):202-6. PubMed ID: 22980124
    [TBL] [Abstract][Full Text] [Related]  

  • 54. GABA(A) receptor subtypes as targets for neuropsychiatric drug development.
    Korpi ER; Sinkkonen ST
    Pharmacol Ther; 2006 Jan; 109(1-2):12-32. PubMed ID: 15996746
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Forward in reverse: how reverse genetics complements chemical genetics.
    Ross-Macdonald P
    Pharmacogenomics; 2005 Jun; 6(4):429-34. PubMed ID: 16004561
    [TBL] [Abstract][Full Text] [Related]  

  • 56. DNAPrint Genomics, Inc.: better drugs for segmented markets.
    Frudakis T
    Pharmacogenomics; 2008 Feb; 9(2):247-51. PubMed ID: 18370852
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Reflections of a geneticist on the influence of genes in psychiatric disorders].
    Penchaszadeh VB
    Vertex; 2016 Sep; XXVII(129):357-367. PubMed ID: 28282073
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Leveraging genetics and genomics to define the causes of mental illness.
    State MW; Geschwind DH
    Biol Psychiatry; 2015 Jan; 77(1):3-5. PubMed ID: 25483342
    [No Abstract]   [Full Text] [Related]  

  • 59. Commercial prospects for genomic sequencing technologies.
    Mohamed S; Syed BA
    Nat Rev Drug Discov; 2013 May; 12(5):341-2. PubMed ID: 23629497
    [No Abstract]   [Full Text] [Related]  

  • 60. Psychiatric Genomics, inc.
    Palfreyman MG
    Pharmacogenomics; 2002 May; 3(3):417-20. PubMed ID: 12052148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.